Home The Word Brain	My Amedeo FAQ Privacy About
	2049 Chinese The 20K Word Road to Mandarin Proficiency By B. S. Kamps et al.

Pulmonary Hypertension

Free Subscription 20.05.2024 1 Am J Respir Cell Mol Biol 2 Am J Respir Crit Care Med 1 Ann Am Thorac Soc 1 Ann Med 1 ASAIO J 2 Autoimmun Rev 1 bioRxiv 1 BMC Pulm Med 1 BMJ Case Rep 1 Cell Mol Biol Lett 1 Circ Res 2 Circulation 1 Clin Respir J 1 Crit Care Med 1 Curr Probl Cardiol 1 Diagnostics (Basel) 1 ESC Heart Fail 2 Eur Respir J 3 Int J Mol Sci 1 J Heart Lung Transplant 1 J Med Life 1 J Med Ultrason (2001) 1 Minerva Cardiol Angiol 1 Nihon Shokakibyo Gakkai Zasshi 2 Pediatr Res 1 Port J Card Thorac Vasc Surg 2 Pulm Circ 1 Respir Res 1 Rheumatology (Oxford) 1 Small

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Respir Cell Mol Biol

1. SAINT-MARTIN WILLER A, El Jekmek K, Antigny F
   Therapeutic Potential of Sodium Houttuyfonate in Pulmonary Hypertension Through Orai-Ca2+ Channels.
   Am J Respir Cell Mol Biol. 2024 May 15. doi: 10.1165/rcmb.2024-0214.
   PubMed        
   
   

   
   Am J Respir Crit Care Med

2. KAWUT SM, Feng R, Ellenberg SS, Zamanian R, et al
   Pulmonary Hypertension and Anastrozole (PHANTOM): A Randomized, Double-Blind, Placebo-Controlled Trial.
   Am J Respir Crit Care Med. 2024 May 15. doi: 10.1164/rccm.202402-0371.
   PubMed         Abstract available
   
   
3. OLDROYD SH, Manek G, Bhardwaj A, Zamanian RT, et al
   Constructing the Framework for Disease Modification in Pulmonary Arterial Hypertension.
   Am J Respir Crit Care Med. 2024;209:1189-1195.
   PubMed         Abstract available
   
   

   
   Ann Am Thorac Soc

4. ZEDER K, Brittain E, Kovacs G, Maron BA, et al
   The Management of Mild Pulmonary Hypertension in Clinical Practice.
   Ann Am Thorac Soc. 2024 May 15. doi: 10.1513/AnnalsATS.202312-1079.
   PubMed         Abstract available
   
   

   
   Ann Med

5. ZHOU R, Lei Y, Ge L, Mao Q, et al
   Accuracy of brain natriuretic peptide and N-terminal brain natriuretic peptide for detecting paediatric pulmonary hypertension: a systematic review and meta-analysis.
   Ann Med. 2024;56:2352603.
   PubMed         Abstract available
   
   

   
   ASAIO J

6. GRATE JC, Reynolds TS, Gordon AC, Dave SB, et al
   Infected Thrombosis Leading to Veno-Venous Extracorporeal Membrane Oxygenation Dysfunction in Chronic Thromboembolic Pulmonary Hypertension.
   ASAIO J. 2024 May 17. doi: 10.1097/MAT.0000000000002233.
   PubMed         Abstract available
   
   

   
   Autoimmun Rev

7. FAVOINO E, Prete M, Liakouli V, Leone P, et al
   Idiopathic and connective tissue disease-associated pulmonary arterial hypertension (PAH): Similarities, differences and the role of autoimmunity.
   Autoimmun Rev. 2024;23:103514.
   PubMed         Abstract available
   
   
8. THOREAU B, Mouthon L
   Pulmonary arterial hypertension associated with connective tissue diseases (CTD-PAH): Recent and advanced data.
   Autoimmun Rev. 2024;23:103506.
   PubMed         Abstract available
   
   

   
   bioRxiv

9. BANERJEE S, Onwunyi VRC, Hong J, Martineau S, et al
   RV-specific Targeting of Snai1 Rescues Pulmonary Hypertension-induced Right Ventricular Failure by Inhibiting EndMT and Fibrosis via LOXL2 Mediated Mechanism.
   bioRxiv [Preprint]. 2024 May 3:2024.04.30.591766. doi: 10.1101/2024.04.30.591766
   PubMed         Abstract available
   
   

   
   BMC Pulm Med

10. YUAN Y, Li S, Yan M, Yang Y, et al
    Genetically determined gut microbiota associates with pulmonary arterial hypertension: a Mendelian randomization study.
    BMC Pulm Med. 2024;24:235.
    PubMed         Abstract available
    
    

    
    BMJ Case Rep

11. CORVOL F, Hascoet S, Le Bret E, Nathan N, et al
    Scimitar syndrome with vein stenosis in an infant.
    BMJ Case Rep. 2024;17:e259955.
    PubMed         Abstract available
    
    

    
    Cell Mol Biol Lett

12. KANG K, Xiang J, Zhang X, Xie Y, et al
    N6-methyladenosine modification of KLF2 may contribute to endothelial-to-mesenchymal transition in pulmonary hypertension.
    Cell Mol Biol Lett. 2024;29:69.
    PubMed         Abstract available
    
    

    
    Circ Res

13. ZHANG J, Li Y, Chen Y, Zhang J, et al
    o(8)G Site-Specifically Modified tRF-1-AspGTC: A Novel Therapeutic Target and Biomarker for Pulmonary Hypertension.
    Circ Res. 2024 May 15. doi: 10.1161/CIRCRESAHA.124.324421.
    PubMed         Abstract available
    
    

    
    Circulation

14. GERHARDT F, Fiessler E, Olsson KM, Kayser MZ, et al
    Positive Vasoreactivity Testing in Pulmonary Arterial Hypertension: Therapeutic Consequences, Treatment Patterns, and Outcomes in the Modern Management Era.
    Circulation. 2024 Apr 12. doi: 10.1161/CIRCULATIONAHA.122.063821.
    PubMed         Abstract available
    
    
15. RUBIN LJ
    Is There a Role for Calcium Channel Blockers in the Contemporary Treatment Paradigm for Pulmonary Arterial Hypertension?
    Circulation. 2024;149:1565-1567.
    PubMed        
    
    

    
    Clin Respir J

16. ZHANG X, Qin H, Ma Q, Zhang J, et al
    CircST6GAL1 knockdown alleviates pulmonary arterial hypertension by regulating miR-509-5p/multiple C2 and transmembrane domain containing 2 axis.
    Clin Respir J. 2024;18:e13771.
    PubMed         Abstract available
    
    

    
    Crit Care Med

17. FLOREZ ID, Parra-Rodas L
    Persistent Pulmonary Hypertension of the Newborn: Should Sildenafil and Inhaled Nitric Oxide at Medium Concentration Be the Standard of Treatment?
    Crit Care Med. 2024;52:995-997.
    PubMed        
    
    

    
    Curr Probl Cardiol

18. ADHYAPAK SM, Konda A, K T T, Shivakumar, et al
    Right heart catheterization in idiopathic pulmonary hypertension: An all-inclusive necessity.
    Curr Probl Cardiol. 2024;49:102642.
    PubMed         Abstract available
    
    

    
    Diagnostics (Basel)

19. NEMATI N, Burton T, Fathieh F, Gillins HR, et al
    Pulmonary Hypertension Detection Non-Invasively at Point-of-Care Using a Machine-Learned Algorithm.
    Diagnostics (Basel). 2024;14:897.
    PubMed         Abstract available
    
    

    
    ESC Heart Fail

20. KRAMER T, Nattmann P, Gerhardt F, Stafiej P, et al
    Impact of rapid sequential combination therapy on distinct haemodynamic measures in newly diagnosed pulmonary arterial hypertension.
    ESC Heart Fail. 2024;11:1540-1552.
    PubMed         Abstract available
    
    

    
    Eur Respir J

21. MA JL, Wang AY, Lu D, Cheng CY, et al
    The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
    Eur Respir J. 2024;63:2301879.
    PubMed        
    
    
22. WISSMULLER M, Wartner V, Hohmann C, Adler J, et al
    Reply to: The puzzles surrounding the impact of face masks on 6-minute walking distance in pulmonary hypertension.
    Eur Respir J. 2024;63:2400529.
    PubMed        
    
    

    
    Int J Mol Sci

23. RIOU M, Coste F, Meyer A, Enache I, et al
    Mechanisms of Pulmonary Vasculopathy in Acute and Long-Term COVID-19: A Review.
    Int J Mol Sci. 2024;25:4941.
    PubMed         Abstract available
    
    
24. CHATZIDAVID S, Flevari P, Tombrou I, Anastasiadis G, et al
    Pulmonary Hypertension in Sickle Cell Disease: Novel Findings of Gene Polymorphisms Related to Pathophysiology.
    Int J Mol Sci. 2024;25:4792.
    PubMed         Abstract available
    
    
25. BAHI M, Li C, Wang G, Korman BD, et al
    Systemic Sclerosis-Associated Pulmonary Arterial Hypertension: From Bedside to Bench and Back Again.
    Int J Mol Sci. 2024;25:4728.
    PubMed         Abstract available
    
    

    
    J Heart Lung Transplant

26. KANEZAWA M, Shimokawahara H, Ejiri K, Goten C, et al
    Effects of medical therapy and age on cardiac output changes following balloon pulmonary angioplasty: Implications for combination therapy in chronic thromboembolic pulmonary hypertension.
    J Heart Lung Transplant. 2024 May 15:S1053-2498(24)01661.
    PubMed         Abstract available
    
    

    
    J Med Life

27. DESAI R, Katukuri N, Kanagala SG, Ghadge N, et al
    Examining prevalence and predictors of pulmonary hypertension in adults with idiopathic pulmonary fibrosis: a population-based analysis in the United States.
    J Med Life. 2024;17:35-40.
    PubMed         Abstract available
    
    

    
    J Med Ultrason (2001)

28. YAMANO M, Yamano T, Matoba S
    Right ventricular dilatation: echocardiographic differential diagnosis.
    J Med Ultrason (2001). 2024;51:275-282.
    PubMed         Abstract available
    
    

    
    Minerva Cardiol Angiol

29. MASARONE D, Falco L, Catapano D, Gravino R, et al
    Dapagliflozin reverses combined postcapillary and precapillary pulmonary hypertension in a patient with advanced heart failure.
    Minerva Cardiol Angiol. 2024 May 16. doi: 10.23736/S2724-5683.24.06592.
    PubMed        
    
    

    
    Nihon Shokakibyo Gakkai Zasshi

30. ATSUKAWA M, Koyano K, Iwakiri K
    [Portopulmonary hypertension (PoPH)].
    Nihon Shokakibyo Gakkai Zasshi. 2024;121:382-388.
    PubMed        
    
    

    
    Pediatr Res

31. BAE SP, Kim SS, Yun J, Lee H, et al
    Neonatal outcomes of preterm infants with pulmonary hypertension: clustering based on prenatal risk factors.
    Pediatr Res. 2024 May 11. doi: 10.1038/s41390-024-03232.
    PubMed         Abstract available
    
    
32. GALIS R, Mudura D, Trif P, Diggikar S, et al
    Milrinone in persistent pulmonary hypertension of newborn: a scoping review.
    Pediatr Res. 2024 May 14. doi: 10.1038/s41390-024-03234.
    PubMed         Abstract available
    
    

    
    Port J Card Thorac Vasc Surg

33. ELSEBAIE A, Enriquez VRB, Baranchuk A, Nahin MA, et al
    Atrial Arrhythmias Following Pulmonary Thromboendarterectomy: A Comprehensive Review Of Current Literature.
    Port J Card Thorac Vasc Surg. 2024;31:41-46.
    PubMed         Abstract available
    
    

    
    Pulm Circ

34. VOHRA AS, Olonoff DA, Ip A, Kirtane AJ, et al
    Nationwide trends of balloon pulmonary angioplasty and pulmonary thromboendarterectomy for chronic thromboembolic pulmonary hypertension (2012-2019).
    Pulm Circ. 2024;14:e12374.
    PubMed         Abstract available
    
    
35. RAWLINGS GH, Gaskell C, Beail N, Thompson A, et al
    Exploratory and confirmatory factor analysis of emPHasis-10: The health-related quality-of-life measure in pulmonary hypertension.
    Pulm Circ. 2024;14:e12378.
    PubMed         Abstract available
    
    

    
    Respir Res

36. HU T, Mu C, Li Y, Hao W, et al
    GPS2 ameliorates cigarette smoking-induced pulmonary vascular remodeling by modulating the ras-Raf-ERK axis.
    Respir Res. 2024;25:210.
    PubMed         Abstract available
    
    

    
    Rheumatology (Oxford)

37. KNIGHT DS, Virsinskaite R, Karia N, Cole AR, et al
    Native myocardial T1 and right ventricular size by CMR predict outcome in systemic sclerosis-associated pulmonary hypertension.
    Rheumatology (Oxford). 2024 May 17:keae141. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Small

38. OH Y, Park K, Jung S, Choi M, et al
    Inhalable Nitric Oxide Delivery Systems for Pulmonary Arterial Hypertension Treatment.
    Small. 2024;20:e2308936.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Pulmonary Hypertension is free of charge.